article thumbnail

Why Data Analytics are Critical in a Value-Based Care (VBC) Environment

AIHC

As more and more potential and real fraud, waste, and abuse was uncovered in the FFS arena, it was also discovered that patient outcomes were less than stellar. The Centers for Medicare & Medicaid Services (CMS) HCC model was initiated in 2004 and is becoming increasingly prevalent as the environment shifts to value-based payment models.

article thumbnail

Why Data Analytics are Critical in a Value-Based Care (VBC) Environment

AIHC

As more and more potential and real fraud, waste, and abuse was uncovered in the FFS arena, it was also discovered that patient outcomes were less than stellar. The Centers for Medicare & Medicaid Services (CMS) HCC model was initiated in 2004 and is becoming increasingly prevalent as the environment shifts to value-based payment models.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Navigating Dual Purpose Communications After SCOTUS (Almost) Weighs in on Attorney-Client Privilege: 5 Practical Tips for Healthcare Attorneys

Healthcare Law Blog

This topic always involves a legal angle, such as Stark Law or Anti-Kickback compliance, or state fraud and abuse law considerations. C-02-1786 JSW (EMC), 245, 248, 2004 U.S. 23, 2004). [4] For example, consider physician compensation. However, it almost always involves a business angle too. Are bonuses involved?

article thumbnail

Pretty Potent Mix In A Prescription Painkiller Preemption Decision

Drug & Device Law

Ohio is one of several states, with New Jersey being the most notable , with statutes precluding punitive damages in product liability cases based on FDA approval or compliance. This was seen most starkly in the non-precedential affirmance of a bad decision on the Michigan statute’s exception in Desiano v. Warner-Lambert & Co. ,

FDA 64
article thumbnail

Applying the Helpful but Problematic New Jersey Statute Creating a Rebuttable Compliance Presumption, the Third Circuit Affirms Dismissal of a Failure-to-Warn Claim

Drug & Device Law

But state-law claims that rest on alleged fraud on the FDA are contrary to Buckman Co. 341 (2001), which concluded that fraud-on-the-FDA claims are impliedly preempted because they “inevitably conflict” with the FDA’s regulatory discretion under. 2022 WL 1261318, at *1 (quoting N.J. Plaintiffs’ Legal Committee , 531 U.S. 21 U.S.C. §